Summary Slide.png (85.24 kB)
Efficacy and Safety of Ivabradine Once-daily Prolonged Release versus Twice-daily Immediate Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction – A Randomized, Double-blind, Phase 3, Non-Inferiority (PROFICIENT) Study
media
posted on 2020-09-17, 14:28 authored by Ajit Mullasari, The PROFICIENT investigatorsThe above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.